Deals, Insight journal - Dealtalk

Valeant moves on to new M&A targets

Posted on 02 May 2011

Tags: , ,

Now that Teva Pharmaceutical Industries has snatched Cephalon, what's next for would-be suitor Valeant Pharmaceuticals?

More deals, naturally...

 

Read the Valeant story at Reuters.

 

Print Friendly, PDF & Email

Leave a Reply

 

cabannerad300x150new4gif
rauconbadgejpg
e80banner300x150animgif
cpbannerad300x150new1gif
e80banner300x150animgif
a1banner300x150animgif